T. Taguchi

I. Adachi2
M. Narabayashi2
S. Takashima1
2I. Adachi
2M. Narabayashi
1S. Takashima
1T. Ohtsu
Learn More
A late phase II clinical trial of RP56976 (docetaxel), derived from Taxus baccata was performed to evaluate anti-tumour activity, time to progression and clinical toxicity in patients with advanced or recurrent breast cancer. The patients, between 15 and 80 years old with performance status (PS) of 0-2, received at least two cycles of docetaxel 60 mg m-2(More)
The crucian carp (Carassius spp.) fishery in Lake Biwa, Shiga Prefecture, Japan, is economically and culturally important. Annual fishery catch, however, has been decimated allegedly due to predation by largemouth bass (Micropterus salmoides) and bluegill (Lepomis macrochirus). This prompted the local government to restore natural stocks by rearing juvenile(More)
To determine the maximum-tolerated doses (MTDs), the dose-limiting toxicities (DLTs) and the recommended doses for further trials of docetaxel in combination with a 5-day continuous infusion of 5-fluorouracil (5-FU) in advanced or recurrent breast cancer patients who had been treated previously with at least one chemotherapeutic regimen, patients were(More)
  • 1